For patients who already established that their commercial plan wont cover a weight-loss GLP-1 or who are on government insurance and excluded from manufacturer savings cards the math is straightforward: Microdose GLP-1 Protocol at $129/mo, Semaglutide Injection at $189/mo, Tirzepatide Injection at $289/mo, or GLP-Squared at $289/mo all at or below branded self-pay maintenance rates, with Microdose and Semaglutide Injection priced below even the lowest-dose branded self-pay tiers
Fu, J., Zheng, Y., Gao, Y., & Xu, W
The patent term mathematics are straightforward: a CIP sacrifices the difference between the parents filing date and the CIPs filing date from the new matter claims effective term, and then loses additional term through terminal disclaimers required to manage ODP
Store reconstituted vials wrapped in foil, in an opaque box, or in an amber vial if one is available